Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹95Cr
Engineering - Light - General
Rev Gr TTM
Revenue Growth TTM
-0.33%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

HOLMARC
VS
| Quarter | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | 11.7 | 17.9 | 21.4 | 3.6 | -4.9 |
| 11 | 13 | 12 | 16 | 15 | 17 | 15 |
Operating Profit Operating ProfitCr |
| 15.0 | 19.1 | 12.9 | 17.6 | 13.2 | 17.4 | 4.3 |
Other Income Other IncomeCr | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| 2 | 4 | 2 | 4 | 2 | 4 | 1 |
| 0 | 1 | 0 | 1 | 0 | 1 | 0 |
|
Growth YoY PAT Growth YoY% | | | 2.9 | -6.3 | 17.0 | 5.5 | -79.8 |
| 8.2 | 15.3 | 7.6 | 12.2 | 7.3 | 12.4 | 1.6 |
| 0.0 | 0.0 | 1.5 | 2.4 | 1.2 | 2.5 | 0.3 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 35.4 | 38.1 | 15.2 | 11.1 | -2.2 |
| 14 | 18 | 24 | 28 | 31 | 32 |
Operating Profit Operating ProfitCr |
| 9.4 | 13.6 | 17.3 | 15.6 | 15.4 | 11.6 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 1 | 1 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 1 | 1 | 1 | 1 | 1 | 1 |
| 1 | 2 | 5 | 5 | 5 | 5 |
| 0 | 1 | 1 | 1 | 1 | 1 |
|
| | 125.6 | 129.5 | -3.6 | 8.8 | -26.4 |
| 4.4 | 7.4 | 12.3 | 10.3 | 10.1 | 7.6 |
| 1.0 | 2.2 | 5.0 | 3.9 | 3.7 | 2.7 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Equity Capital Equity CapitalCr | 0 | 0 | 7 | 10 | 10 |
| 7 | 8 | 4 | 14 | 17 |
Current Liabilities Current LiabilitiesCr | 3 | 3 | 3 | 2 | 3 |
Non Current Liabilities Non Current LiabilitiesCr | 3 | 4 | 2 | 2 | 2 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 7 | 8 | 11 | 20 | 23 |
Non Current Assets Non Current AssetsCr | 5 | 7 | 6 | 8 | 9 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 0 | 3 | 2 | 2 | 3 |
Investing Cash Flow Investing Cash FlowCr | -1 | -2 | 0 | -2 | -2 |
Financing Cash Flow Financing Cash FlowCr | 0 | 0 | -1 | 7 | 0 |
|
Free Cash Flow Free Cash FlowCr | 0 | 1 | 2 | -1 | 1 |
| 59.8 | 166.5 | 57.8 | 45.5 | 83.7 |
CFO To EBITDA CFO To EBITDA% | 28.2 | 90.4 | 41.0 | 29.9 | 54.4 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 0 | 81 | 140 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 23.6 | 37.4 |
Price To Sales Price To Sales | 0.0 | 0.0 | 0.0 | 2.4 | 3.8 |
Price To Book Price To Book | 0.0 | 0.0 | 0.0 | 3.4 | 5.1 |
| 0.6 | 0.2 | -0.2 | 13.8 | 22.7 |
Profitability Ratios Profitability Ratios |
| 79.6 | 75.6 | 75.3 | 76.5 | 80.2 |
| 9.4 | 13.6 | 17.3 | 15.6 | 15.4 |
| 4.4 | 7.4 | 12.3 | 10.3 | 10.1 |
| 12.8 | 23.1 | 39.1 | 19.8 | 18.2 |
| 10.0 | 18.8 | 30.7 | 14.4 | 13.8 |
| 5.5 | 10.6 | 21.5 | 12.4 | 11.7 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Holmarc Opto-Mechatronics Limited is a leading Indian manufacturer of precision scientific and engineering instruments. Established in **1993** and headquartered in **Kochi, Kerala**, the company operates at the intersection of **optics, mechanics, electronics, and software**. Holmarc transitioned to a public entity via the **NSE EMERGE (SME)** platform in **September 2023**, becoming the first Kerala-based company to list on this segment.
---
### Multidisciplinary Product Ecosystem & R&D Pipeline
Holmarc operates as a single-segment entity providing integrated engineering tools for high-end research across photonics, nanotechnology, and atmospheric science. The company is currently executing a strategic pivot to adapt its research-grade technology for the **clinical and diagnostic healthcare markets**.
| Category | Key Products & Strategic Value |
| :--- | :--- |
| **Spectroscopy** | **Confocal Micro Raman Spectrometers** and **Spectrophotometers with DRS**; offered at **50% of the price** of foreign incumbents. |
| **Microscopy** | **Automated Microscopes** for QC; **Probe Station Microscopes**; and new **Automated Microscopic Image Analysis** systems for healthcare OEMs. |
| **Nanotechnology** | **Nano Fiber Electro-spinning Stations** (no other domestic manufacturer in India) and **2D Material Transfer Systems**. |
| **Laser Systems** | **UV Laser Mask-Less Lithography** and **Multi-wavelength Laser Scribing/Ablation** stations. |
| **Healthcare (New)** | **PCR & RTPCR Machines** (manufacturing to commence **FY 2025-26**) and clinical diagnostic imaging tools. |
| **Solar/PV Testing** | **Light Beam Induced Current (LBIC)** systems using triple lasers for semiconductor defect mapping. |
**Strategic R&D Focus:** Management has placed development in unrelated engineering fields **on hold** to concentrate resources on core spectroscopy and healthcare-aligned products to drive immediate sales growth.
---
### Manufacturing Scalability & "Mission Kerala 1000"
Under the Kerala Government’s **Mission Kerala 1000** program, Holmarc aims to reach a **₹100 crore turnover** within four years. This is supported by a phased expansion of production capacity and a focus on increasing in-factory value addition to over **60%**.
**Production Capacity Targets:**
* **Phase I (Completed March 2024):** **₹3 Crore** per month.
* **Phase II (Completed Sept 2024):** **₹4 Crore** per month.
* **Phase III (Target April 2025):** **₹5 Crore** per month.
* **Long-term Target:** **30% YoY Growth** post-FY 2025-26.
**Infrastructure Expansion:**
* **Land Acquisitions (2025):** Acquired **10.625 cents** (B3 Shed) and **28.5 cents** (A4 Shed) in the **HMT Industrial Estate**, Kochi.
* **Technological Upgrades:** Investment in automated **Physical Vapor Deposition (PVD)** for optical coating and precision surface grinding for motion control.
* **In-house Production:** In FY2025, the company built **14 units of capital equipment** internally to reduce reliance on external vendors.
---
### Market Penetration & Global Distribution
Holmarc is transitioning from a "direct-to-researcher" model to a diversified industrial sales approach, leveraging both government tenders and a growing dealer network.
**Sales Performance & Reach:**
* **Government Tenders:** A primary revenue driver; secured **142 out of 233 tenders** in the latest fiscal year (**61% success rate**).
* **Dealer Network:** Appointed **63 domestic dealers** to target the Pharma, Defense, Aerospace, and Jewelry sectors.
* **Export Growth:** Export revenue rose to **₹6.05 Crore** (+15.69%) in FY25. The company now exports to **60 countries**, with a **135.68% surge** in German market sales.
* **International Expansion:** Establishing a sales/service office in the **UAE (Sept 2025)** to target GCC and African markets, with future plans for the **USA and EU**.
| Metric | FY 2023-24 | FY 2024-25 |
| :--- | :--- | :--- |
| **Domestic Customers** | 438 | **458** |
| **Foreign Customers** | 98 | **117** |
| **Top Export Market** | USA | **USA (₹95.35 Lakhs)** |
| **Private Sector Share** | Not Specified | **42.56% of Turnover** |
---
### Financial Performance & IPO Capital Utilization
The company achieved its highest-ever turnover in FY 2023-24, supported by the successful deployment of IPO proceeds.
| Financial Metric | FY 2023-24 | FY 2022-23 | Growth (%) |
| :--- | :--- | :--- | :--- |
| **Revenue from Operations** | **₹33.46 Crore** | **₹29.04 Crore** | **15.24%** |
| **Profit Before Tax (PBT)** | **₹4.57 Crore** | **₹4.08 Crore** | **12.18%** |
**Capital Allocation:**
* **IPO Proceeds:** **₹11.40 Crore** raised (**28,50,000 shares at ₹40**).
* **Status:** Capital equipment purchases are **complete**. Working capital infusion is scheduled for completion by **March 31, 2025**.
* **Inventory:** Work in Progress (WIP) accounts for **₹99.87 lakhs** (**35.08%** of total inventory), valued using the **weighted average method**.
---
### Human Capital & Productivity Targets
Holmarc’s growth strategy relies heavily on "Productivity-Led Expansion" rather than just headcount growth.
* **Workforce:** **355 employees** (as of March 2025), with **24.33%** female representation.
* **Efficiency Goal:** A target of **10% YoY increase** in employee productivity through **2028**.
* **Management Objective:** Achieve a **50% increase in production** through automation and design optimization without further increasing the current headcount.
---
### Risk Factors & Governance
Investors should monitor the following operational and regulatory challenges:
* **Market Lag & Overheads:** Recent performance was impacted by high rents and consumables in anticipation of market growth that has been slower than expected.
* **Governance Restructuring:** In **May 2025**, **five Whole-time Directors** resigned from the Board to restore the balance between Independent and Non-Independent Directors. They remain as **Senior Management** to ensure operational continuity.
* **Compliance:** The company noted a **119-day delay** in filling the **CFO vacancy** in early 2024, exceeding the 3-month statutory limit under **SEBI (LODR)**.
* **Operational Risks:** Includes **input cost volatility**, **technological obsolescence**, and **unreliable power supply** at manufacturing sites.
* **Competitive Landscape:** Facing pressure from low-cost imports; Holmarc counters this through **import substitution** strategies and aggressive pricing (e.g., 50% lower than foreign peers).